Form 4: Jazz Pharmaceuticals Director Sells Shares
Insider Transaction (Form 4)
Bruce C Cozadd, a Director of Jazz Pharmaceuticals plc, sold 6,000 shares of common stock on August 31, 2026 for $250.13 per share.
Summary
- Tax/exercise-price withholding: disposed of 10 Ordinary Shares at $244.06 ($2,441) on August 31, 2026; holds 359,084 after (Direct).
- Tax/exercise-price withholding: disposed of 1,209 Ordinary Shares at $241.39 ($291,840) on August 31, 2026; holds 357,875 after (Direct).
- Open-market sale: disposed of 6,000 Ordinary Shares at $250.13 ($1,500,780) on September 1, 2026; holds 351,875 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $1,500,780 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Bruce C Cozadd — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 10 | $244 | $2.4K | 359,084 |
| 2026-08-31 | Tax/exercise-price withholding | Ordinary Shares | 1,209 | $241 | $291.8K | 357,875 |
| 2026-09-01 | Open-market sale | Ordinary Shares | 6,000 | $250 | $1.5M | 351,875 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-31 | Tax/exercise-price withholding (10 shares) |
| 2026-08-31 | Tax/exercise-price withholding (1,209 shares) |
| 2026-09-01 | Open-market sale (6,000 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, bearish, Bruce C Cozadd
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.